2020-09-09
Products from SMOORE's First Batch Completed PMTA Filing Stage
On September 1, 2020, the local time in the U.S., according to the PMTA audit receipt provided by the U.S. Food and Drug Administration (hereinafter referred to as "FDA"), SMOORE International Holdings Co., Ltd. (hereinafter referred to as "SMOORE") own brand VAPORESSO has become the first vaping brand in the industry to complete the filing stage of PMTA review. The announcement indicates that VAPORESSO’s first batch products submitted to the FDA, with their high-quality, have quickly passed the first two rounds of rigorous review. Meanwhile, completing the filing stage also represents that products of VAPORESSO have entered the final stage of the PMTA application process.